Medicare Part D coverage · colchicine · RxCUI 1550946
colchicine 0.6 MG Oral Capsule [Mitigare]
Per the CMS 2026 Part D formulary file, colchicine 0.6 MG Oral Capsule [Mitigare] is covered by 217 Medicare Part D plans (4.3% of enrollable products), averaging Tier 2.6, with prior authorization required on 0% of covering formularies.
- 4.3%
- Plan coverage
- 217
- Plans covering
- T2.6
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for colchicine 0.6 MG Oral Capsule [Mitigare]
Per the CMS 2026 Part D formulary file, colchicine 0.6 MG Oral Capsule [Mitigare] (RxNorm concept RXCUI 1550946, generic name colchicine) appears on 11 distinct formulary files spanning 217 Medicare Part D plan offerings - 4.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 3, with a cross-plan average of Tier 2.6.
Real-world access to colchicine 0.6 MG Oral Capsule [Mitigare] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 100% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 553,640 Part D beneficiaries filled colchicine 0.6 MG Oral Capsule [Mitigare] in 2023, with total plan-and-beneficiary spending of $99,038,149 and an average per-beneficiary annual cost of $178.89. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry colchicine 0.6 MG Oral Capsule [Mitigare] today.
Coverage Details
- Formularies covering
- 11
- Plans covering
- 217
- Coverage rate
- 4.3%
- Tier range
- Tier 2 – Tier 3
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 100% of formularies
2023 Medicare Spending
- Beneficiaries
- 553,640
- Total spending
- $99,038,149
- Avg per beneficiary
- $178.89
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering colchicine 0.6 MG Oral Capsule [Mitigare]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| BlueCare Plus (HMO D-SNP) | Volunteer State Health Plan | T2 | No | $0 | TN |
| BlueCare Plus Choice (HMO D-SNP) | Volunteer State Health Plan | T2 | No | $0 | TN |
| BlueCare Plus Select (HMO D-SNP) | Volunteer State Health Plan | T2 | No | $0 | TN |
| Prominence Plus (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Giveback (HMO) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Plus (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Plus (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Plus (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Beyond (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Giveback (HMO) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Beyond (HMO-POS) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
Show the next 30 plans
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst | T2 | No | $0 | NV |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Florida Inc | T2 | No | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Diabetes and Heart Care Plus (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | Prominence Healthfirst OF Texas | T2 | No | $0 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst | T2 | No | $4.20 | NV |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Florida Inc | T2 | No | $4.80 | FL |
| Prominence Extra Help (HMO) | Prominence Healthfirst OF Texas | T2 | No | $4.80 | TX |
| Prominence Extra Help (HMO) | Prominence Healthfirst | T2 | No | $9.50 | NV |
| HealthSpring Preferred (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Alliance (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred Savings (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred Full Savings (HMO) | Bravo Health Pennsylvania, Inc. | T3 | No | $0 | AZ |
| HealthSpring Preferred GA (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | GA |
| HealthSpring Preferred (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | MO |
| HealthSpring Preferred Savings (HMO) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | MO |
| HealthSpring Premier (HMO-POS) | Healthspring Life & Health Insurance Company, Inc. | T3 | No | $0 | UT |
| HealthSpring Preferred (HMO) | Healthspring Healthcare OF Colorado, Inc. | T3 | No | $0 | NM |
| HealthSpring Preferred (HMO) | Healthspring Healthcare OF Colorado, Inc. | T3 | No | $0 | OH |
| HealthSpring Preferred (HMO) | Healthspring Healthcare OF Colorado, Inc. | T3 | No | $0 | KY, OH |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is colchicine 0.6 MG Oral Capsule [Mitigare] covered by Medicare Part D?
Yes, colchicine 0.6 MG Oral Capsule [Mitigare] is covered by 217 Medicare Part D plans (4.3% of all Part D formularies).
What tier is colchicine 0.6 MG Oral Capsule [Mitigare] on Medicare Part D plans?
colchicine 0.6 MG Oral Capsule [Mitigare] averages Tier 2.6 across Part D plans, ranging from Tier 2 to Tier 3.
Does colchicine 0.6 MG Oral Capsule [Mitigare] require prior authorization?
0% of Part D formularies require prior authorization for colchicine 0.6 MG Oral Capsule [Mitigare]. Step therapy: 0%. Quantity limits: 100%.
How much does Medicare spend on colchicine 0.6 MG Oral Capsule [Mitigare]?
In 2023, total Medicare Part D spending on colchicine 0.6 MG Oral Capsule [Mitigare] was $99,038,149, covering 553,640 beneficiaries. The average spend per beneficiary was $178.89.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA